Clinical ResearchInterventional CardiologyOptimal Timing for the Initiation of Pre-Treatment With 300 mg Clopidogrel Before Percutaneous Coronary Intervention
Interventional Cardiology
Under an Elsevier user license
open archive
Abbreviations and Acronyms
GP
glycoprotein
MI
myocardial infarction
PCI
percutaneous coronary intervention
UTVR
urgent target vessel revascularization
Cited by (0)
The CREDO trial was sponsored by Bristol-Myers Squibb and Sanofi-Aventis. Dr. Steinhubl received research support from and served as a consultant for Bristol-Myers Squibb, Sanofi-Aventis, and The Medicines Company, and served as a consultant for AstraZeneca and Accumetrics.
Copyright © 2006 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.